Not All Postmenopausal Women on Chronic Steroid and Estrogen Treatment are Osteoporotic: Predictors of Bone Mineral Density

[1]  C. Slemenda,et al.  Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri-, and postmenopausal women. , 1996, The Journal of clinical investigation.

[2]  J Dequeker,et al.  Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. , 1995, The New England journal of medicine.

[3]  S. Cummings,et al.  Rheumatoid arthritis and bone mineral density in elderly women , 1995 .

[4]  J. Kanis,et al.  DIAGNOSIS OF OSTEOPOROSIS , 2016 .

[5]  L. Raisz,et al.  Glucocorticoid-induced osteoporosis. , 1994, Rheumatic diseases clinics of North America.

[6]  B. Lukert.  Glucocorticoid‐Induced Osteoporosis , 1992, Rheumatic diseases clinics of North America.

[7]  T. Spector,et al.  The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women. , 1993, Arthritis and rheumatism.

[8]  J. Eisman,et al.  Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin. , 1993, The New England journal of medicine.

[9]  J. Eisman,et al.  Determinants of axial bone loss in rheumatoid arthritis. , 1987, Arthritis and rheumatism.

[10]  I. Reid,et al.  Calcium supplements in the prevention of steroid-induced osteoporosis. , 1986, The American journal of clinical nutrition.

[11]  I. Reid,et al.  Low serum osteocalcin levels in glucocorticoid-treated asthmatics. , 1986, The Journal of clinical endocrinology and metabolism.

[12]  W. Murphy,et al.  Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases. , 1985, Arthritis and rheumatism.

[13]  C. Christiansen,et al.  The effect of glucocorticoids on bone mass in rheumatoid arthritis patients. Influence of menopausal state. , 1985, Arthritis and rheumatism.

[14]  L. Melton,et al.  Fractures after rheumatoid arthritis. A population-based study. , 1984, Arthritis and rheumatism.

[15]  Y. Ichikawa,et al.  Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy. , 1983, Metabolism: clinical and experimental.

[16]  S. Teitelbaum,et al.  Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration. , 1979, The Journal of clinical investigation.